MRK vs. ABBV
Compare and contrast key facts about Merck & Co., Inc. (MRK) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRK or ABBV.
Correlation
The correlation between MRK and ABBV is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRK vs. ABBV - Performance Comparison
Loading data...
Key characteristics
MRK:
-1.51
ABBV:
0.53
MRK:
-2.07
ABBV:
0.91
MRK:
0.73
ABBV:
1.14
MRK:
-0.93
ABBV:
0.81
MRK:
-1.74
ABBV:
1.93
MRK:
23.27%
ABBV:
8.68%
MRK:
27.72%
ABBV:
28.32%
MRK:
-68.62%
ABBV:
-45.09%
MRK:
-42.42%
ABBV:
-15.37%
Fundamentals
MRK:
$192.42B
ABBV:
$332.08B
MRK:
$6.60
ABBV:
$2.20
MRK:
11.13
ABBV:
80.65
MRK:
0.70
ABBV:
0.38
MRK:
3.01
ABBV:
5.79
MRK:
3.98
ABBV:
220.73
MRK:
$63.92B
ABBV:
$57.37B
MRK:
$51.75B
ABBV:
$44.44B
MRK:
$27.30B
ABBV:
$16.33B
Returns By Period
In the year-to-date period, MRK achieves a -24.16% return, which is significantly lower than ABBV's 4.16% return. Over the past 10 years, MRK has underperformed ABBV with an annualized return of 5.91%, while ABBV has yielded a comparatively higher 15.47% annualized return.
MRK
-24.16%
-4.58%
-22.68%
-41.53%
2.76%
5.91%
ABBV
4.16%
2.76%
9.11%
14.96%
19.78%
15.47%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRK vs. ABBV — Risk-Adjusted Performance Rank
MRK
ABBV
MRK vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MRK vs. ABBV - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 4.22%, more than ABBV's 3.51% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 4.22% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.42% | 3.11% |
ABBV AbbVie Inc. | 3.51% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
MRK vs. ABBV - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.62%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for MRK and ABBV. For additional features, visit the drawdowns tool.
Loading data...
Volatility
MRK vs. ABBV - Volatility Comparison
Merck & Co., Inc. (MRK) has a higher volatility of 12.24% compared to AbbVie Inc. (ABBV) at 11.53%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
MRK vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MRK vs. ABBV - Profitability Comparison
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.